- Home
- Products
Empaveli (Pegcetacoplan)
Empaveli (Pegcetacoplan)
- Medicine Name: Empaveli
- Generic Name: Pegcetacoplan
- Dosage Form & Strength: Injection – 1,080 mg/20 mL (54 mg/mL) in a single-dose vial
- Manufactured By: Apellis Pharmaceuticals, Inc.
Empaveli is a complement inhibitor used for the treatment of adults diagnosed with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder that can lead to hemolysis (destruction of red blood cells).
Recommended Dosage:
- Patients must receive vaccinations against encapsulated bacteria (Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae type B) at least 2 weeks before starting Empaveli.
- If immediate therapy is required, vaccines may be administered promptly, along with a 2-week course of antibiotics.
- The standard dose is 1,080 mg via subcutaneous infusion twice weekly, delivered through an infusion pump with a minimum 20 mL reservoir.
If a dose is missed, administer it as soon as possible, and then resume the regular schedule.
Severe Infections: Use of Pegcetacoplan may increase the risk of life-threatening infections caused by encapsulated bacteria. Monitor closely for early signs of infection.
Vaccination Requirement: Vaccination is mandatory before starting treatment. If therapy begins before vaccination, antibiotic prophylaxis is required.
Hypersensitivity Reactions: Systemic allergic reactions, including anaphylaxis, may occur. Stop treatment and initiate appropriate medical care if symptoms develop.
Post-Treatment Monitoring: After stopping Empaveli, monitor patients for at least 8 weeks for signs of hemolysis or recurrence of PNH symptoms.
Pregnancy and Breastfeeding: Women of childbearing potential should use contraception during and for 40 days after treatment. Avoid breastfeeding during and for 40 days post-therapy.
Required Documents for Importing Empaveli into India:
- Valid prescription from a registered medical professional
- Diagnostic reports supporting the condition
- Government-issued ID proof of the patient
Availability in India:
Empaveli is a prescription-only biologic therapy and may be imported legally under the Named Patient Program for patients who require access to this treatment.
Global Rare Meds Supports:
- Secure sourcing from certified suppliers in the USA, Canada, Europe, and Australia
- Import assistance and transparent pricing
- Delivery to major cities like Mumbai, Delhi, Hyderabad, Bengaluru, Pune, Kolkata, Chennai, Ahmedabad, and others
Order Confirmation:
Processing begins upon receipt of a valid prescription and, where required, an import permit.
📧 info@globalraremeds.com
📞 +91-99675 15602 (Call/WhatsApp)
Global Rare Meds sources Empaveli from trusted global distributors and ensures regulated import and delivery. All medications are dispatched from our licensed fulfillment center in Ambernath, Thane District, India.
Every order is:
- Verified by certified pharmacists
- Packed securely to maintain cold chain and integrity
- Delivered directly to the patient or hospital
Q: What is the generic name of Empaveli®?
A: Pegcetacoplan
Q: Who manufactures Empaveli®?
A: Apellis Pharmaceuticals, Inc.
Q: Is Empaveli® approved by the FDA?
A: Yes, Empaveli received FDA approval on May 14, 2021.
Q: What is the strength and dosage form of Empaveli®?
A: Injection: 1,080 mg/20 mL (54 mg/mL) for subcutaneous administration.
Q: What are the common side effects of Empaveli®?
A: Side effects may include injection-site reactions, abdominal pain, viral infections, respiratory infections, diarrhea, and fatigue.
Q: How should Empaveli® be stored?
A: Store between 2°C and 8°C in the original carton to protect from light. Do not freeze or use beyond the expiration date.
Q: What is the cost of Empaveli® in India?
A: Prices vary based on availability and source. For accurate cost, contact info@globalraremeds.com or call/WhatsApp +91-99675 15602.
Q: Can Empaveli® be imported legally into India?
A: Yes. With proper documentation and prescription, Global Rare Meds can facilitate the legal import of Empaveli for eligible patients in India.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
